Article
Oncology
Mathias Schneeweiss-Gleixner, Georg Greiner, Susanne Herndlhofer, Julia Schellnegger, Maria-Theresa Krauth, Karoline Gleixner, Friedrich Wimazal, Corinna Steinhauser, Michael Kundi, Renate Thalhammer, Ilse Schwarzinger, Gregor Hoermann, Harald Esterbauer, Manuela Fodinger, Peter Valent, Wolfgang R. Sperr
Summary: Although iron overload is a clinical challenge, little is known about the clinical impact of HFE-variants in myelodysplastic syndromes. The study found that HFE-variants H63D and C282Y are frequently detected in Austrian MDS patients, who have higher ferritin levels at diagnosis, accumulate iron slightly faster, and have a better progression-free survival than non-mutated patients.
AMERICAN JOURNAL OF CANCER RESEARCH
(2021)
Review
Immunology
Sarah Weber, Anastasia Parmon, Nina Kurrle, Frank Schnuetgen, Hubert Serve
Summary: MDS and AML patients often experience systemic iron overload issues, iron is closely associated with the pathogenesis and potential treatment strategies of the diseases, imbalances in iron homeostasis may lead to various cell death.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Social Sciences, Interdisciplinary
Mathias Schneeweiss-Gleixner, Georg Greiner, Susanne Herndlhofer, Julia Schellnegger, Maria-Theresa Krauth, Karoline Gleixner, Friedrich Wimazal, Corinna Steinhauser, Michael Kundi, Renate Thalhammer, Ilse Schwarzinger, Gregor Hoermann, Harald Esterbauer, Manuela Foedinger, Peter Valent, Wolfgang R. Sperr
Summary: In this study, HFE-variants H63D and C282Y were frequently detected in Austrian MDS patients, who had higher ferritin levels at diagnosis, accumulated iron slightly faster, and had better progression-free survival than non-mutated patients.
COGENT SOCIAL SCIENCES
(2021)
Article
Oncology
Lap Shu Alan Chan, Lilly ChunHong Gu, Richard A. Wells
Summary: In this study, iron was found to be a promoter of leukemogenesis in mice up to a peak iron dose, but further iron loading decreased the risk of AML. Iron chelation therapy showed partial effectiveness in reducing the incidence of AML, but intervention should be done before extreme iron overload to maximize its benefits.
Article
Chemistry, Medicinal
Hana Votavova, Zuzana Urbanova, David Kundrat, Michaela Dostalova Merkerova, Martin Vostry, Monika Hruba, Jaroslav Cermak, Monika Belickova
Summary: DFX improves hematopoiesis in anemic myelodysplastic syndrome patients by modulating immune response, suppressing negative regulators of blood cell differentiation, and upregulating heme metabolism.
Review
Medicine, General & Internal
Toni Valkovic, Marija Stanic Damic
Summary: Iron plays an important role in the survival and reproduction of fungal pathogens, and there is evidence linking invasive fungal infections to iron or iron overload. Understanding the association between iron and iron overload with susceptibility to invasive fungal infections is crucial, especially for patients with hematological malignancies.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Medicine, General & Internal
Felicitas Schulz, Ulrich Hauch, Sandra Ketzler-Henkel, Eyck von der Heyde, Michael Koenigsmann, Michael Lauseker, Nora Schulte, Ulrich Germing
Summary: Myelodysplastic syndromes and myeloproliferative neoplasms are hematologic diseases associated with bone marrow failure, and transfusion of red blood cells is necessary but leads to iron overload. Therefore, iron chelation therapy plays a crucial role in anemic patients.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Oncology
Laurent Pascal
Summary: Iron overload is harmful to elderly patients with low-risk myelodysplastic syndromes (MDS), especially those with cardiovascular disease. A randomized study has shown improved event-free survival with Iron Chelation Therapy (ICT) in these patients. Further research is needed to better understand the benefits of ICT.
BULLETIN DU CANCER
(2023)
Article
Radiology, Nuclear Medicine & Medical Imaging
Gerard M. Healy, Stephan A. R. Kannengiesser, Osvaldo Espin-Garcia, Richard Ward, Kevin H. M. Kuo, Kartik S. Jhaveri
Summary: Inline R-2*-LIC provides robust and comparable quantification of LIC compared to FerriScan, without the need for offline post-processing.
EUROPEAN RADIOLOGY
(2021)
Article
Hematology
John Chapin, Alan R. Cohen, Ellis J. Neufeld, Elliott Vichinsky, Patricia J. Giardina, Jeanne Boudreaux, Binh C. Le, Kristy Kenney, Sean Trimble, Alexis A. Thompson
Summary: Thalassaemia is a genetic disorder causing anaemia and dependence on transfusions, with recent clinical advancements leading to reduced mortality and potential future gene therapies. Research revealed older patients with more iron-related comorbidities and complications, while younger patients had excess liver and heart iron and were on combination chelation therapy.
BRITISH JOURNAL OF HAEMATOLOGY
(2022)
Article
Medicine, General & Internal
Christina Fragodimitri, Vasiliki Schiza, Anastasios Giakoumis, Kalliopi Drakaki, Anastasia Salichou, Fotis Karampatsos, Jacqueline Yousef, Markissia Karageorga, Vasili Berdoukas, Athanasios Aessopos
Summary: This study analyzed the benefits of the revolution in the management of beta-thalassemia major. The results showed that chelation therapy significantly optimized the indices and increased the proportion of patients with chelation success. Continuous magnetic resonance imaging and prolonged intensified chelation therapy can help patients achieve clearance of cardiac and liver iron load and reduce mortality.
Review
Chemistry, Analytical
Zahra Tariq, Muhammad Imran Qadeer, Iram Anjum, Christophe Hano, Sumaira Anjum
Summary: Thalassemia is a monogenic autosomal recessive disorder caused by mutations, which affect hemoglobin production. Conventional therapeutic methods such as transfusion and iron chelation therapy have limitations, leading to the demand for advanced therapies. Nanotechnology-based applications have emerged as simple, convenient, and cost-effective methods for theragnostics. This review summarizes the potential of nanotechnology in developing theragnostic approaches for diagnosing thalassemia-causing gene mutations and employing nano-based therapeutic procedures.
Article
Hematology
Federica Pilo, Giovanni Caocci, Giannalisa Mele, Giorgio La Nasa
Summary: The study found that the degree of iron accumulation in the bone marrow detected by Perls staining is associated with the overall survival of MDS patients. A higher grade of iron storage is correlated with lower survival rates. Additionally, bone marrow iron overload and transfusion dependency negatively impact on patient survival.
ACTA HAEMATOLOGICA
(2021)
Review
Multidisciplinary Sciences
Yesim Aydinok
Summary: Combination chelation therapy is a viable option for transfusion-dependent thalassemia patients who have not achieved iron balance with monotherapy or need intensified treatment for rapid iron reduction. It allows for a more personalized approach, improving tolerability, adherence, and quality of life. Real-life data highlights the importance of compliance in achieving meaningful reduction in iron overload compared to monotherapy.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
(2023)
Review
Cardiac & Cardiovascular Systems
Shizhen Li, Xiangyu Zhang
Summary: Iron plays essential roles in cardiovascular diseases, with iron deficiency having detrimental effects in heart failure and pulmonary arterial hypertension patients. Ferroptosis, an iron-dependent cell death, has been reported in cardiomyopathy, atherosclerotic cardiovascular disease, and myocardial ischemia/reperfusion injury. Iron chelation therapy may be a potential strategy to address iron overload-related disorders in CVD.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)